Website: mitoq.com
Overview
MitoQ Limited is a New Zealand-based company focused on cellular health through advanced mitochondrial supplements. Founded in the late 1990s by Professors Mike Murphy and Robin Smith at the University of Otago, MitoQ has developed a patented molecule that targets mitochondria, delivering antioxidants directly to combat cellular stress and enhance overall cellular function.
The company offers a range of products supported by over 600 independent research papers and 12 clinical trials from prestigious institutions, including Harvard Medical School and UCLA. MitoQ emphasizes a science-backed approach to cellular health, aiming to empower health-conscious individuals in the U.S. and China to improve their vitality and metabolic health. With around 72 employees and approximately $6 million in revenue, MitoQ holds 60 global patents, highlighting its leadership in mitochondrial-targeted health technology.
The company offers a range of products supported by over 600 independent research papers and 12 clinical trials from prestigious institutions, including Harvard Medical School and UCLA. MitoQ emphasizes a science-backed approach to cellular health, aiming to empower health-conscious individuals in the U.S. and China to improve their vitality and metabolic health. With around 72 employees and approximately $6 million in revenue, MitoQ holds 60 global patents, highlighting its leadership in mitochondrial-targeted health technology.
Est Monthly Spend
---
Repeat Buy Rate
---
Direct Response
---
Est. Spend
No spend data available
Top Shows
Ads
Recent Campaigns